Cutaneous Lupus Erythematosus Clinical Trials

41 clinical trials for Cutaneous Lupus Erythematosus across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease — RECRUITING · PHASE3
• A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus — RECRUITING · PHASE2
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — RECRUITING · PHASE2
• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) — RECRUITING · PHASE3
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — RECRUITING · PHASE2
• Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study — RECRUITING · PHASE2
• Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease — RECRUITING · PHASE1
• Tapinarof for Cutaneous Lupus Erythematosus — RECRUITING · PHASE1
• Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus — RECRUITING
• Research Accelerated by You Lupus Registry — RECRUITING
• Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants — RECRUITING · PHASE1
• A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults — NOT_YET_RECRUITING · PHASE1
• A Multicenter, Randomized, Double‑blind, Placebo‑controlled, Phase III Study to Evaluate the Efficacy and Safety of Anifrolumab in Adults with Chronic and/or Subacute Cutaneous Lupus Erythematosus who are Refractory and/or Intolerant to Antimalarial Therapy — TERMINATED · PHASE3
• A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus — ACTIVE_NOT_RECRUITING · PHASE3
• A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants with Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations. — TERMINATED · PHASE2
• LEISURE : Lenalidomide vs methotrexate in difficult-to-treat cutaneous lupus erythematosus (LEISURE trial): An assessor-blinded randomized clinical trial — TERMINATED · PHASE3
• Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) — TERMINATED · PHASE2
• Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. — NOT_YET_RECRUITING · PHASE1
• The effect of anifrolumab on cutaneous lupus erythematosus characterized by the change of the inflammatory infiltrate analyzed by immunohistochemistry, spatial transcriptomics and single-cell RNA- and TCR-sequencing as well as on the clinical outcome - an open label, single arm phase IV pilot study — TERMINATED · PHASE4
• The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE — NOT_YET_RECRUITING · PHASE1
• A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus — ACTIVE_NOT_RECRUITING · PHASE1
• Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus — COMPLETED · PHASE2
• Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus — NOT_YET_RECRUITING · PHASE3
• A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis — COMPLETED · PHASE1
• Deep Phenotyping of Cutaneous Lupus Erythematosus — OTHER · NA
• Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) — TERMINATED · PHASE1
• Study of M5049 in CLE and SLE Participants — COMPLETED · PHASE1
• Low-dose UVA1 Radiation in Cutaneous Lupus Patients — COMPLETED · NA
• Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) — COMPLETED · NA
• Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus — OTHER · PHASE2
• To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus — COMPLETED · PHASE2
• Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) — COMPLETED · PHASE2
• Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) — COMPLETED · NA
• IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus — COMPLETED · PHASE1
• A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus — TERMINATED · PHASE1
• Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) — COMPLETED
• Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus — TERMINATED · PHASE2
• Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus — COMPLETED · NA
• Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser — COMPLETED · PHASE2
• Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) — COMPLETED · PHASE2
• Sunscreen RV 2457C in Photoinduced CLE — COMPLETED · PHASE3

Refine this search